Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics describes the effect and consequences of when ER-p53 tumors attach to mutant p53. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
The Effect of ER-p53 Combined With Mutant p53
